Napolitano Francesco, Napolitano Paola, Liguori Giorgio, Angelillo Italo Francesco
a Department of Experimental Medicine ; Second University of Naples ; Naples , Italy.
b Chair of Hygiene; University of Naples "Parthenope," ; Naples , Italy.
Hum Vaccin Immunother. 2016 Jun 2;12(6):1504-10. doi: 10.1080/21645515.2016.1156271. Epub 2016 Apr 12.
This study assessed knowledge and attitudes about Human papillomavirus (HPV) and the relative vaccination and their determinants in a sample of young males. The survey was conducted between January and April 2015 among a sample of 1000 males aged between 14-24 y in the geographic area of Naples and Caserta, Italy. The 54.9% of the participants reported of having heard about the HPV infection. Those who were aware about the availability of the vaccine, who reported the first vaginal sexual encounter before the 18 y and at least at 18 y compared to those who had not had a complete sexual intercourse, who had undergone a health checkup in the last year, and who had received information about the HPV vaccine by physicians had a significant higher knowledge about the HPV infection. The 58.2% reported that they would be willing to receive the HPV vaccine. Those younger, who reported the first vaginal sexual encounter at least at 18 y, who agreed that male should receive the vaccine, who knew that both males and females can acquire the infection, and who agreed that the vaccine is an important preventive intervention, expressed more positive attitude toward willingness to receive the vaccine. More information about the HPV vaccine were required by those who agreed that the vaccine is an important preventive intervention, who reported the first vaginal sexual encounter at least at 18 y, who have had only one partner in the last year compared to students who had no partner, and who had received information about the vaccine by physicians. This study highlights a need for improved education of young males of the HPV infection and the associated diseases and about the benefit of the vaccination.
本研究评估了年轻男性样本中关于人乳头瘤病毒（HPV）及其相关疫苗接种的知识、态度及其决定因素。该调查于2015年1月至4月在意大利那不勒斯和卡塞塔地区1000名年龄在14 - 24岁的男性样本中进行。54.9%的参与者报告听说过人乳头瘤病毒感染。与那些没有过完全性行为的人相比，那些知道有疫苗可用、报告首次阴道性行为在18岁之前以及至少在18岁、在过去一年接受过健康检查、并从医生那里获得过人乳头瘤病毒疫苗信息的人，对人乳头瘤病毒感染的了解程度显著更高。58.2%的人报告他们愿意接种人乳头瘤病毒疫苗。那些更年轻、报告首次阴道性行为至少在18岁、同意男性应该接种疫苗、知道男性和女性都可能感染、并同意疫苗是一种重要预防干预措施的人，对愿意接种疫苗表达了更积极的态度。那些同意疫苗是一种重要预防干预措施、报告首次阴道性行为至少在18岁、与没有伴侣的学生相比在过去一年只有一个伴侣、并从医生那里获得过疫苗信息的人，需要更多关于人乳头瘤病毒疫苗的信息。本研究强调需要加强对年轻男性关于人乳头瘤病毒感染及其相关疾病以及疫苗接种益处的教育。
